drugset / Trial / NCT05095337

Study to Evaluate the Mass Balance and Biotransformation of [14C]SHR1459 in Healthy Adult Male Volunteers

NCT05095337

Phase 1 Unknown 6 enrolled Jiangsu HengRui Medicine Co., Ltd.
NaSingle-groupOpen-labelOther

Summary

Evaluate the Mass Balance and Biotransformation of \[14C\]SHR1459 in Healthy Adult Male Volunteers

Timeline

Start
2022-06-07
Primary completion
2022-07-05
Completion
2022-07-25

Drugs

EvaluationDrugModalityDoseRoute
Subject EDRALBRUTINIB Small molecule Oral

Indications

No indication recorded.